AKT1 and prostate carcinoma: Our study suggests, that factors which regulate the hypoxic signals and thereby lead to the untoward activation of the ERK and AKT pathways, might be suitable therapeutic targets for prostate cancer metastasis, namely the HIF1 multi-protein transcriptional complex.